Publications by authors named "Petr Jansky"

Claim this Profile
N
Newly identified cerebral microbleeds in patients on anticoagulation for secondary stroke prevention.
Tereza Šrámková, Tomáš Vaňásek, Martin Šrámek, Petr Janský, Kateřina Benešová

Medicine (Baltimore)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recanalization Outcomes and Procedural Complications in Patients With Acute Ischemic Stroke and COVID-19 Receiving Endovascular Treatment.
João Pedro Marto, Davide Strambo, George Ntaios, Thanh N Nguyen, Pawel Wrona

J Stroke· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNAs and other biomarkers of atrial fibrillation in ischemic stroke patients.
Petr Janský, Vojtěch Kaplan, Tereza Šrámková, Filip Kolman, Petra Kloudová

Medicine (Baltimore)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of ABCB1 and CES1 Polymorphisms on Plasma Levels of Dabigatran and Risk of Hemorrhagic Complications in Ischemic Stroke Patients.
Anna Olšerová, Petr Janský, Hana Magerová, Tereza Šrámková, Petra Kešnerová

Am J Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of patient selection in clinical trials: application of ROCKET AF and ARISTOTLE criteria in GARFIELD-AF.
Jelle C L Himmelreich, Saverio Virdone, John Camm, Karen Pieper, Ralf E Harskamp, Petr Jansky

Open Heart· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective tax rates of multinational corporations: Country-level estimates.
Javier Garcia-Bernardo, Petr Janský, Thomas Tørsløv

PLoS One· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rhythm versus rate control in patients with newly diagnosed atrial fibrillation - Observations from the GARFIELD-AF registry.
Marita Knudsen Pope, Trygve S Hall, Saverio Virdone, Dan Atar, A John Camm, Petr Jansky

Int J Cardiol Heart Vasc· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural connectivity-based predictors of cognitive impairment in stroke patients attributable to aging.
Barbora Rehák Bučková, David Kala, Jakub Kořenek, Veronika Matušková, Vojtěch Kumpošt

PLoS One· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Outcome of Revascularization Treatment in Patients With Acute Ischemic Stroke and COVID-19: The Global COVID-19 Stroke Registry.
João Pedro Marto, Davide Strambo, George Ntaios, Thanh N Nguyen, Roman Herzig

Neurology· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial.
Kelley R H Branch, Gilles R Dagenais, Alvaro Avezum, Jan Basile, Ignacio Conget, Petr Jansky

Eur J Heart Fail· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On-treatment Comparative Effectiveness of Vitamin K Antagonists and Direct Oral Anticoagulants in GARFIELD-VTE, and Focus on Cancer and Renal Disease.
Sylvia Haas, Alfredo E Farjat, Karen Pieper, Walter Ageno, Pantep Angchaisuksiri, Petr Jansky

TH Open· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial.
Tali Cukierman-Yaffe, Hertzel C Gerstein, Jan Basile, M Angelyn Bethel, Ernesto G Cardona-Muñoz, Petr Jansky

J Clin Endocrinol Metab· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trial.
Peter J Raubenheimer, William C Cushman, Alvaro Avezum, Jan Basile, Ignacio Conget, Petr Jansky

Diabetes Obes Metab· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing prevalence of hypertension during long-term follow-up in children with autosomal dominant polycystic kidney disease.
Tomáš Seeman, Petr Jansky, Fencl Filip, Květa Bláhová, Adam Jaroš

Pediatr Nephrol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data.
Marita Knudsen Pope, Trygve S Hall, Valentina Schirripa, Petra Radic, Saverio Virdone, Petr Jansky

BMJ· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants.
Jackie Bosch, Eva M Lonn, Hyejung Jung, Jun Zhu, Lisheng Liu, Petr Jansky

Eur Heart J· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin.
Giulia Ferrannini, Hertzel Gerstein, Helen Martina Colhoun, Gilles R Dagenais, Rafael Diaz, Petr Jansky

Eur Heart J· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetic algorithm for predicting daily dose of warfarin in Caucasian patients of Czech origin.
Aleš Tomek, Tereza Růžičková, Vojtěch Kaplan, Zuzana Lacinová, Simona Kumstýřová

Drug Metab Pers Ther· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial.
Hertzel C Gerstein, Robert Hart, Helen M Colhoun, Rafael Diaz, Mark Lakshmanan, Petr Jansky

Lancet Diabetes Endocrinol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF.
Freek W A Verheugt, Giuseppe Ambrosio, Dan Atar, Jean-Pierre Bassand, A John Camm, Petr Jansky

Am J Med· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis.
Jurrien M Ten Berg, Anne de Veer, Jonas Oldgren, Philippe Gabriel Steg, Dmitry A Zateyshchikov, Petr Jansky

JACC Cardiovasc Interv· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Warfarin loading dose guided by pharmacogenetics is effective and safe in cardioembolic stroke patients - a randomized, prospective study.
Tereza Ruzickova, Martin Sramek, Vojtech Kaplan, Simona Kumstyrova, Zuzana Lacinova, Petr Jansky

Pharmacogenomics J· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Hertzel C Gerstein, Helen M Colhoun, Gilles R Dagenais, Rafael Diaz, Mark Lakshmanan, Petr Jansky

Lancet· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Hertzel C Gerstein, Helen M Colhoun, Gilles R Dagenais, Rafael Diaz, Mark Lakshmanan, Petr Jansky

Lancet· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE Substudy.
John D Horowitz, Raffaele De Caterina, Tamila Heresztyn, John H Alexander, Ulrika Andersson, Petr Jansky

J Am Coll Cardiol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis